Skip to content

Z+PHARMA

Active
Public limited companyfounded 1994active for 32 yearsStatiestraat 131, 2070 Beveren-Kruibeke-Zwijndrecht, BelgiumKBO/BCE: BE 0453.060.967
Risk analysisFollow ReportCompare
Z+PHARMAActiveChecked score 88/100
Risk analysis ReportCompare

Directors

Directors
6 directors, last change in 2023

Board 6

Colruyt Jozef
Director · since 31-05-2023 · listed in the 2026 annual accounts, filed on 21-09-2026
Current
Kris Castelein
Director · since 31-05-2023 · term without a fixed end · listed in the 2026 annual accounts, filed on 21-09-2026
Current
Stefaan Vandamme
Director · appointed in the act of 18-08-2023 · term without a fixed end
Current
Stefan Goethaert
Director · since 31-05-2023 · term without a fixed end · listed in the 2026 annual accounts, filed on 21-09-2026
Current
Willemyns Jo
Director · since 31-05-2023 · listed in the 2026 annual accounts, filed on 21-09-2026
Current
Hamelrijck Lichael
Director · since 01-08-2026 · listed in the 2026 annual accounts, filed on 21-09-2026
Current

Statutory auditor 1

Ernst et Young Reviseurs d'Entreprises
Statutory auditor · appointed in the act of 18-11-2024 · permanent representative: Emilie VAN CALLEMONT
Current
Office holders in the KBO →
Signing authorityThe articles say who may bind the company, for example by signing a contract.
Two directors jointly
deed of 10-05-2024

Owners and capital

Shareholders

2 owners

Chain of control

  1. COSIFARMA 100%
  2. Z+PHARMA

Owners 2

Capital transactions

Capital over time
  1. 06-12-2024 Capital stated in the deed · €61,500 · 750 shares

Mandate history

10 people, 7 in office
Show
  • Board
  • Statutory auditor
  • began earlier
  • end not dated
Mandates per person, with start and end dates
Name Functions and periods
Colruyt Jozef
  • Director, from 31-05-2023 to date
Kris Castelein
  • Director, from 31-05-2023 to date
Stefaan Vandamme
  • Director, appointed in the act of 18-08-2023, still in office
Stefan Goethaert
  • Director, from 31-05-2023 to date
Willemyns Jo
  • Director, from 31-05-2023 to date
Hamelrijck Lichael
  • Director, from 01-08-2026 to date
Ernst et Young Reviseurs d'Entreprises
  • Statutory auditor, appointed in the act of 18-11-2024, still in office
Jef Colruyt
  • Director, appointed in the act of 18-08-2023, no longer listed in the 2026 annual accounts
Jo Willemyris
  • Director, appointed in the act of 18-08-2023, no longer listed in the 2026 annual accounts
COSIFARMA
  • Director, until 31-05-2023

Articles of association

Liquidation ruleIn a liquidation the creditors are paid first. What is left goes to the shareholders.
“Alle verrichtingen vermeld in wet, tenzij algemene vergadering anders besluit bij gewone meerderheid”

Articles of association, deed of 06-12-2024 (in Dutch)

Next steps

See this company's board, registered office and name on a given date.Company as of a date See what became of the directors' other companies.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file

We would like to set cookies. That happens only with your consent. What we measure